Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Leap Therapeutics (LPTX – Research Report) and Immunovant (IMVT – Research Report). Leap ...
Leap, a full-stack international student mobility platform, has raised $65 million through a mix of primary and secondary equity, led by Apis Growth Markets Fund III and Apis Global Growth Fund III.
The updated corporate presentation posted on Leap Therapeutics’ website on the same day provided further insight into the potential of sirexatamab (DKN-01) in various cancer treatments ...